S213-1713 Screening compound: 1-(3-ethylphenyl)-3-methyl-3-[(oxolan-3-yl)methyl]urea

S213-1713 Screening compound: 1-(3-ethylphenyl)-3-methyl-3-[(oxolan-3-yl)methyl]urea
S213-1713 Screening compound: 1-(3-ethylphenyl)-3-methyl-3-[(oxolan-3-yl)methyl]urea alternative view

Chemical Structure Depiction of ChemDiv screening compound S213-1713
1-(3-ethylphenyl)-3-methyl-3-[(oxolan-3-yl)methyl]urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S213-1713

Molecular Formula

C15H22N2O2 (C15 H22 N2 O2)

Compound Name

1-(3-ethylphenyl)-3-methyl-3-[(oxolan-3-yl)methyl]urea

IUPAC name

1-(3-ethylphenyl)-3-methyl-3-[(oxolan-3-yl)methyl]urea

SMILES

CCc1cccc(NC(N(C)CC2COCC2)=O)c1

InChI

InChI=1S/C15H22N2O2/c1-3-12-5-4-6-14(9-12)16-15(18)17(2)10-13-7-8-19-11-13/h4-6,9,13H,3,7-8,10-11H2,1-2H3,(H,16,18)/t13-/m1/s1

InChI Key

LPERJUOMTSCSDZ-CYBMUJFWSA-N

MDL Number (MFCD)

MFCD30462382

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

262.35

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

2.769

Distribution Coefficient, logD

2.769

Water Solubility, LogSw

-3.05

Polar Surface Area

34.174

Acid Dissociation Constant (pKa)

13.78

Base Dissociation Constant (pKb)

1.87

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

53.33

S213-1713 in Drug Discovery

Included in Screening Libraries

3D-Fragment Library (4274 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

GABA Library (7115 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Fragments
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Eye
  • Cancer
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Targets:
  • GPCR
  • Ion Channels

References: we are preparing a list of scientific research reports with S213-1713 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S213-1713?
Check Price and Availability of S213-1713, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S213-1713 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S213-1713
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S213-1713
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S213-1713 available by request